KLEANTHIS G. XANTHOPOULOS - 10 Jun 2021 Form 4 Insider Report for Zosano Pharma Corp

Role: Director
Signature: /s/ Steven Lo, Attorney-in-Fact for Kleanthis G. Xanthopoulos
Issuer symbol: N/A
Transactions as of: 10 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 14 Jun 2021, 20:35:18 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ZSAN	Common Stock	Award	$0	+15,000	+174%	$0.000000	23,596	10 Jun 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZSAN	Stock Option (Right to Buy)	Award	$0	+30,000		$0.000000	30,000	10 Jun 2021	Common Stock	30,000	$0.9318	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units which vest in a single installment on the earlier of (i) the first anniversary of the grant date and (ii) immediately prior to the annual meeting in 2022 of the Issuer's stockholders, assuming continuous service through such vesting date.
F2	The option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date and (ii) immediately prior to the annual meeting in 2022 of the Issuer's stockholders, assuming continuous service through such vesting date.